Branch retinal vein occlusion: Classification and treatment

Research output: Contribution to journalArticle


Branch retinal vein occlusion (BRVO) refers to a heterogeneous group of disorders with different clinical aspects, courses, and probably therapy. Depending on the site of the arteriovenous crossing, we can roughly divide BRVO into 3 main groups: major BRVO, hemispheric retinal vein occlusion, and macular BRVO. Main treatment options include laser treatment, corticosteroid administration, anti-VEGF drugs, and sheathotomy with or without vitrectomy. Laser photocoagulation, as demonstrated by the Branch Vein Occlusion Study, represents the gold standard for the treatment of macular edema and ocular neovascularization following BRVO. The limited functional outcomes achievable by means of laser treatment have prompted researchers to try alternative options, with varying results. The recent introduction of combined therapies for macular edema may provide a superior approach in an attempt to improve and stabilize visual acuity over a long-term follow-up.

Original languageEnglish
Pages (from-to)298-305
Number of pages8
Issue number5
Publication statusPublished - Aug 2009


  • Anti-vascular endothelial growth factor
  • Branch retinal vein occlusion
  • Combined therapy
  • Corticosteroids
  • Laser treatment
  • Sheathotomy
  • Vitrectomy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Fingerprint Dive into the research topics of 'Branch retinal vein occlusion: Classification and treatment'. Together they form a unique fingerprint.

  • Cite this